相关实验视频

Updated: Jun 14, 2025

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique

Published on: March 14, 2016

皮拉鲁比辛与TLR3或TLR4激动剂相结合,可以提高抗瘤效率

Ruobing Zhang¹, Nai-Peng Cui², Yanqiu He³

¹Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Affiliated Hospital of Hebei University, Baoding, 071000 Hebei, China; Clinical Medical College, Hebei University, Baoding, 071000 Hebei, China; Department of Breast Surgery, Affiliated Hospital of Hebei University, Baoding, 071000 Hebei, China.

International immunopharmacology

|September 6, 2024

概括

将托尔类受体 (TLR) 激活剂与皮拉鲁比 (THP) 化疗结合起来,可以克服三阴性乳腺癌的耐药性. 这种策略逆转了抑制的TLR表达,抑制了癌细胞的生长和迁移,并改善了患者的预后.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

由于治疗目标有限,三阴性乳腺癌 (TNBC) 经常复发.
巨细胞是瘤微环境 (TME) 中的关键免疫细胞,影响癌症的进展.
向巨细胞与癌细胞的通信提供了一个有前途的抗瘤战略.

研究的目的:

研究托尔类受体 (TLRs) 在TNBC中的作用.
评估结合TLR激动剂与化疗 (皮拉鲁比辛,THP) 的疗效.
了解这种组合对TME和癌细胞行为的影响.

主要方法:

使用RT-PCR和西欧斑块检测到TLR3和TLR4表达.
通过体外共同培养评估了癌细胞-巨细胞通信.
使用MTT和伤试验评估瘤细胞的增殖和迁移.
通过免疫组织化学和H&E染色分析药物组合效应和毒性.

主要成果:

在TNBC组织中较低的TLR3/4表达与更差的预后相关.
巨细胞共同培养和THP治疗抑制了TLR3/4的表达.
结合TLR激动剂和THP可以逆转这种抑制.
这种组合抑制了乳腺癌细胞的增殖和迁移.
在体内研究表明,瘤体积/体重减少,TLR3/4表达增加.

结论:

THP与TLR激动剂的组合为TNBC提供了一种新的治疗策略.
这种方法可以改善治疗结果和患者的预后.
恢复TLR表达是这种组合疗法的关键机制.

关键词:

在LPS中使用LPS.在MPLA中,MPLA就是一个MPLA.在Pirarubicin中使用Pirarubicin 在 Poly IC IC 中使用.收费类受体的收费类受体.三阴性乳腺癌是三阴性乳腺癌.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...